Ludwig Kappos Selected Research

Ludwig Kappos Research Topics

Disease

214	Multiple Sclerosis 05/2024 - 01/2003
76	Relapsing-Remitting Multiple Sclerosis 12/2023 - 05/2003
20	Chronic Progressive Multiple Sclerosis 07/2023 - 12/2010
18	Infections 10/2023 - 02/2010
16	Disease Progression 07/2023 - 06/2004
15	Atrophy 01/2024 - 12/2010
10	Progressive Multifocal Leukoencephalopathy 01/2021 - 01/2008
9	Inflammation (Inflammations) 01/2024 - 02/2007
9	Bradycardia 10/2018 - 02/2010
7	Atrioventricular Block 11/2019 - 02/2010
6	Lymphopenia (Lymphocytopenia) 01/2022 - 06/2014
5	Stroke (Strokes) 01/2024 - 09/2004
5	Fatigue 01/2021 - 03/2006
5	Human Influenza (Influenza) 01/2019 - 02/2011
4	Demyelinating Diseases (Demyelinating Disease) 02/2024 - 12/2011
4	Herpes Zoster 01/2018 - 02/2010
4	Hypertension (High Blood Pressure) 01/2018 - 02/2010
4	Neoplasms (Cancer) 01/2017 - 06/2014
4	Headache (Headaches) 10/2016 - 10/2008
3	Ganglion Cysts (Ganglion) 02/2024 - 04/2023
3	Body Weight (Weight, Body) 10/2023 - 01/2021
3	Neuromyelitis Optica (Devic's Disease) 01/2023 - 03/2015
3	Autoimmune Diseases (Autoimmune Disease) 01/2023 - 12/2016
3	Abdominal Pain (Pain, Abdominal) 12/2021 - 10/2008
3	Respiratory Tract Infections (Respiratory Tract Infection) 12/2021 - 10/2014
3	Macular Edema 06/2021 - 02/2010
3	Flushing 05/2019 - 10/2008
3	Diarrhea 01/2016 - 10/2011
3	Nausea 01/2016 - 10/2011
2	Pancreatitis 04/2024 - 12/2021
2	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2024 - 01/2008
2	Neuroinflammatory Diseases 01/2024 - 01/2019
2	Nervous System Diseases (Neurological Disorders) 01/2024 - 10/2018
2	Acute Disease 07/2023 - 01/2022
2	Central Nervous System Diseases (CNS Diseases) 01/2023 - 01/2017
2	Myasthenia Gravis 11/2022 - 01/2019
2	Rett Syndrome (Rett's Disorder) 03/2022 - 01/2021
2	Nasopharyngitis 12/2021 - 10/2016
2	Opportunistic Infections (Opportunistic Infection) 11/2019 - 05/2007
2	Exanthema (Rash) 05/2019 - 10/2015

Drug/Important Bio-Agent (IBA)

47	Fingolimod Hydrochloride (FTY720)FDA Link 09/2023 - 09/2006
38	Biomarkers (Surrogate Marker)IBA 02/2024 - 12/2010
32	Natalizumab (Tysabri)FDA Link 01/2023 - 03/2006
29	teriflunomideIBA 04/2024 - 10/2011
26	Dimethyl FumarateIBA 01/2022 - 10/2008
22	InterferonsIBA 02/2021 - 05/2003
19	Interferon beta-1a FDA Link 01/2024 - 10/2007
18	ocrelizumabIBA 10/2023 - 11/2011
16	AntibodiesIBA 01/2023 - 01/2007
15	Interferon beta-1b (Betaseron)FDA Link 01/2020 - 08/2007
12	Interferon-betaIBA 01/2021 - 02/2004
11	siponimodIBA 09/2022 - 08/2013
11	GadoliniumIBA 01/2022 - 11/2012
10	Monoclonal AntibodiesIBA 10/2023 - 01/2008
10	Immunoglobulin G (IgG)IBA 01/2023 - 01/2007
8	ozanimodIBA 10/2022 - 01/2019
8	EnzymesIBA 12/2021 - 02/2010
7	Immunoglobulins (Immunoglobulin)IBA 01/2024 - 02/2011
7	Myelin-Oligodendrocyte GlycoproteinIBA 01/2023 - 01/2007
7	Sphingosine-1-Phosphate ReceptorsIBA 09/2022 - 05/2014
7	Immunologic Factors (Immunomodulators)IBA 01/2020 - 02/2012
6	Proteins (Proteins, Gene)FDA Link 07/2023 - 06/2015
6	AntigensIBA 11/2022 - 02/2011
5	Immunoglobulin M (IgM)IBA 12/2023 - 01/2007
5	Complement System Proteins (Complement)IBA 12/2023 - 01/2011
5	ofatumumab FDA Link 10/2023 - 01/2020
5	Glatiramer Acetate (Copaxone)FDA Link 01/2021 - 11/2006
5	Daclizumab (Zenapax)FDA Link 01/2021 - 09/2016
5	Transaminases (Aminotransferases)IBA 01/2018 - 09/2012
5	Neutralizing AntibodiesIBA 06/2012 - 02/2004
4	IronIBA 02/2024 - 11/2014
4	laquinimodIBA 01/2020 - 03/2012
4	Alanine Transaminase (SGPT)IBA 01/2016 - 03/2014
4	Therapeutic UsesIBA 08/2013 - 02/2004
3	Retinaldehyde (Retinal)IBA 02/2024 - 04/2023
3	Oligoclonal BandsIBA 01/2023 - 04/2015
3	Cytidine Diphosphate (CDP)IBA 01/2022 - 01/2018
3	Alemtuzumab (Campath)FDA Link 01/2022 - 11/2012
3	Vitamin D FDA LinkGeneric 01/2020 - 03/2014
3	hydroxide ionIBA 01/2019 - 08/2014
3	MicroRNAs (MicroRNA)IBA 06/2016 - 07/2012
3	temelimabIBA 10/2015 - 06/2015
3	Influenza Vaccines (Influenza Vaccine)FDA Link 03/2015 - 02/2011
3	Neuroprotective AgentsIBA 03/2015 - 09/2004
3	ImmunosorbentsIBA 10/2013 - 01/2013
2	insulin receptor-related receptor (IRR)IBA 01/2024 - 05/2019
2	Surface Antigens (Surface Antigen)IBA 12/2023 - 09/2009
2	Cladribine FDA LinkGeneric 01/2022 - 01/2020
2	Rituximab (Mabthera)FDA Link 01/2022 - 01/2019
2	VaccinesIBA 11/2021 - 10/2014
2	Minocycline (Cyclops)FDA LinkGeneric 01/2020 - 03/2015
2	CytokinesIBA 01/2020 - 12/2007
2	Matrix Metalloproteinases (MMPs)IBA 01/2020 - 02/2004
2	Hemagglutinins (Hemagglutinin)IBA 01/2019 - 01/2017

Therapy/Procedure

57	Therapeutics 05/2024 - 02/2004
5	Immunomodulation 10/2019 - 06/2004
3	Cognitive Training 01/2015 - 06/2006
2	Immunotherapy 01/2023 - 01/2019
2	Treatment Delay 01/2022 - 11/2009
2	Precision Medicine 11/2021 - 09/2021